Results 41 to 50 of about 767 (113)

Abstracts

open access: yesMolecular Oncology, Volume 19, Issue S1, Page 1-940, June 2025.
Abstracts submitted to the ‘EACR 2025 Congress: Innovative Cancer Science’, from 16–19 June 2025 and accepted by the Congress Organising Committee are published in this Supplement of Molecular Oncology, an affiliated journal of the European Association for Cancer Research (EACR).
wiley   +2 more sources

Dezocine Exerts Analgesic Effects in Chronic Pain by Activation of κ‐ and μ‐Opioid Receptors and Inhibition of Norepinephrine and Serotonin Reuptake

open access: yesPain Research and Management, Volume 2025, Issue 1, 2025.
Background: Dezocine is a leading analgesic in China used for relieving moderate to severe pain. Previous studies have characterized its pharmacological properties, demonstrating its role as a partial agonist at both the κ‐opioid receptor (KOR) and the μ‐opioid receptor (MOR), thereby producing potent antinociceptive effects in acute pain models ...
Zihan Liu   +8 more
wiley   +1 more source

Integrated computational strategies for Polypharmacological profiling and identification of anti‐inflammatory targets in Rungia pectinata L.

open access: yesJournal of Cellular and Molecular Medicine, Volume 28, Issue 23, December 2024.
Abstract Rungia pectinata L. is an ethnomedicinal herb belonging to the Acanthaceae family and it presents a promising avenue for medicinal exploration, deeply rooted in traditional practices. Earlier research has demonstrated that the herb can effectively relieve the classic symptoms of inflammation.
Alaiha Zaheen   +3 more
wiley   +1 more source

Publication Only

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +2 more sources

Evaluation of the Mevalonate Pathway as a Target for the Treatment of Ovarian Cancer [PDF]

open access: yes, 2018
Ovarian cancer is the 5th leading cause of cancer-related death. The disease responds initially to treatment which is most often surgical cytoreduction followed by chemotherapy.
Abdullah, Marwan Ibrahim
core  

Patient's Understanding and Attititudes Towards Infliximab and Etanercept Biosimilars [PDF]

open access: yes, 2017
BackgroundInfliximab and etanercept biosimilars present significant potential cost savings to the NHS. Patients need to be involved in the decision to use these medicines but there is a limited published literature on their knowledge and attitudes about ...

core   +1 more source

Antimicrobial nano-ninjas as chaperones of gemcitabine for pancreatic cancer [PDF]

open access: yes, 2019
Pancreatic cancer is well known for its extremely high death rate, with the current treatments purely used to extend and better the quality of the patient's life instead of providing a “cure”. Because of this, novel drug delivery methods are being looked
Foulkes, Rachel Louise
core  

Cumulin and FSH cooperate to regulate inhibin B and activin B production by human granulosa-lutein cells in vitro [PDF]

open access: yes, 2019
Meeting abstract, from the 35th Annual Meeting of the European Society of Human Reproduction and ...
Mottershead
core   +1 more source

Virtual patient educational programme to teach counselling to clinical pharmacists: development and proof of concept [PDF]

open access: yes, 2019
Pharmacist–patient counselling can benefit patients and optimise care, but appropriate training is required. A virtual patient (VP) tool to teach pharmacists non-vitamin K oral anticoagulant counselling was developed; the VP may be used for continuing ...
White
core  

Modifications of human growth differentiation factor 9 to improve the generation of embryos from low competence oocytes

open access: yes, 2015
Growth differentiation factor 9 (GDF9) is an oocyte-derived growth factor that plays a critical role in ovarian folliculogenesis and oocyte developmental competence and belongs to the TGF-ß family of proteins.

core   +1 more source

Home - About - Disclaimer - Privacy